chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Rash in arm, chest, back and stomach; This spontaneous case was reported by a patient and describes the occurrence of RASH (Rash in arm, chest, back and stomach) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M21A) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: J&J Vaccine (Lot number :1805029  and Route Intramuscular.) on 14-Mar-2021. Past adverse reactions to the above products included No adverse event with J&J Vaccine. Concurrent medical conditions included Hypothyroidism. Concomitant products included LEVOTHYROXINE for Hypothyroidism.    On 17-Jun-2022, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (Rash in arm, chest, back and stomach). The patient was treated with PREDNISONE at a dose of 10 milligram for 5 days; LEVOCETIRIZINE at a dose of 5 milligram for 30 days and AMMONIUM LACTATE at an unspecified dose and frequency. At the time of the report, RASH (Rash in arm, chest, back and stomach) had not resolved.
Development of cellulitis at the site of injection roughly 8 days following injection (no symptoms prior). Started as a small raised rash over the injection site, and spread to about a 6 inch radius, raised, red, hot to touch rash. Benadryl and cortisone cream did not work. Urgent care PA prescribed cephalexin 500 mg 4x/day for 1 week 2 days later. Seeing improvements (duller red color, not as raised, diameter remains same so far).
Soon after the vaccine I started noticing pain at the injection site and my arm got red, really red. Cherry red. It was just for a couple of days and nothing like the 1st dose. Much milder and did not last as long. I can still see the outline of where the redness was in my arm, my skin is still dark where it was. But it does not bother me.
I have been breastfeeding with no additional supplements needed since October 10, 2021. I was both feeding my baby and pumping 40+ ounces a day. After receiving the vaccine due to workplace mandate my supply dropped to 6 ounces a day by the second day after vaccine was received. I now can no longer breastfeed or pump to nourish my baby.
This spontaneous report as received from a certified medical assistant refers to a unspecified number of patients of unknown age and gender. On an unknown date the patients were vaccinated with unspecified number of doses of ROTATEQ, orally (dose, frequency and indication were not reported). The patient were vaccinated after the age of 8 months and 0 days. No adverse events have been reported. Additional information has been requested.
subacute thyroiditis, hyperthyroid, 2 weeks, fever, increased heart rate, body aches, weight loss, abnormal liver enzymes.  Did not improve until prescribed first atenolol and then metoprolol,
pt states large red hard knot on tricep area of right arm that became hot to touch about a day after her vaccine, she states that it started at the injection site.  Swelling has decreased but redness, itching and small hive appearing areas are spreading.  States that ice packs and hydrocortisone cream help decrease the itching.
Intense fever and chills and body pain. Woke me up at 11:30. Blasted all the heaters, took TYLENOL at about midnight, finally went back to sleep around 2:00. By 6:00 the TYLENOL wore off and I was in agonizing pain and chills again. More TYLENOL solved the problem although I feel completely wiped out. I wasn't sick before getting the flu shot. This is truly an adverse reaction. I usually have a little bit of a reaction after the flu shot (some pain and chills) but nothing this bad.
severe abdominal pain; nausea; vomiting; bowels have been getting smaller and smaller, and have been really hard to excrete; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (severe abdominal pain), NAUSEA (nausea), VOMITING (vomiting) and FUNCTIONAL GASTROINTESTINAL DISORDER (bowels have been getting smaller and smaller, and have been really hard to excrete) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     The patient's past medical history included No adverse event.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced ABDOMINAL PAIN (severe abdominal pain), NAUSEA (nausea), VOMITING (vomiting) and FUNCTIONAL GASTROINTESTINAL DISORDER (bowels have been getting smaller and smaller, and have been really hard to excrete). On 20-Feb-2021, VOMITING (vomiting) outcome was unknown. At the time of the report, ABDOMINAL PAIN (severe abdominal pain), NAUSEA (nausea) and FUNCTIONAL GASTROINTESTINAL DISORDER (bowels have been getting smaller and smaller, and have been really hard to excrete) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications reported. Treatment included Tylenol and Tums.
Pt admitted  on March 17, 2021 for "possible blood clots", swelling and redness noted in R Leg, snoring respirations.  Pt discharged on 3/21/2021.
Elevated blood pressure; shortness of breath; swelling in feet; aching joints; This is a spontaneous report from a contactable consumer. A 70-years-old female patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot Number: EN6202), dose 1 via an unspecified route of administration, administered in Arm Right on 26Feb2021 08:30 as dose 1, single, dose 2 via an unspecified route of administration, administered in Arm Left on 19Mar2021 (Batch/Lot Number: EN6207) as dose 2, single for covid-19 immunisation (at the age of 70 years). Medical history included allergies from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 14Mar2021 05:00 PM patient experienced Elevated blood pressure, shortness of breath, swelling in feet, aching joints. When confirmed that the side effects happened with the first shot and confirmed the side effects from the second dose, consumer stated, I am having same problem except it's little worst. The patient was not received treatment. The adverse event result in any doctor or other healthcare professional office/clinic visit. The outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
Systemic: Confusion-Mild, Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Shakiness-Mild
No adverse events happened, vaccine was expired but was given due to not right expiration date in database. So vaccine was not pulled from fridge.
73-year-old male past medical history of CAD, A-fib, hypertension, short-term memory loss, nursing home resident presents to the ER due to shortness of breath.  Patient states that has been more short of breath today.  He has also been less alert than baseline.  He was difficult to arouse this morning at the nursing facility.  He was unable to take his medications.  He was sent to the ER for evaluation.  Patient tested positive for COVID 2 days ago was started on molnupiravir.  No reported chest pain, focal weakness, headache.  No reported abdominal pain   Clinical Summary Patient was admitted to hospital for management of acute hypoxic respiratory failure in the setting of COVID-19 infection.  He was placed on Decadron and remdesivir.  Initially he was kept on empiric antibiotics in the case of superimposed bacterial infection as CT scan did show atelectasis versus infiltrate in the lower lobes.  His oxygenation was continually monitored.  4/5 he was continued on 3 L nasal cannula.  Procalcitonin was checked and was negative so antibiotics were de-escalated.  On 4/6 the patient's oxygenation had significantly improved and he was doing well on room air.  He did develop acute onset nausea and vomiting that was not relieved with Compazine.  KUB was obtained and showed severe gaseous distention of the stomach.  CT abdomen and pelvis was done to rule out small bowel obstruction and no obstruction was seen.  4/7 his nausea and vomiting had resolved and he was tolerating a regular diet.  His mentation had improved to baseline.  Patient was stable for discharge back to skilled nursing facility and was transferred back to facility on 4/7.   Discharge diagnosis COVID 19 infection Acute hypoxic respiratory failure -resolved  Nausea and vomiting - resolved  Metabolic encephalopathy - resolved  Hyponatremia -r esolved  Paroxysmal atrial fibrillation 1st degree AVB Chronic HFpEF Essential hypertension Hypothyroidism Morbid obesity BMI 49.3
Narrative:  93 year old male, received first dose of COVID-19 vaccine (Moderna) on 2/4/2021. Was admitted to ED 1/31/2021 for hallucinations, UTI and weakness. PMH of HTN, DM Type II, CAD s/p 3VCABG in 2006, s/p PPM placement, CKD Stage IV and HTN. Patient was discharged to SAR 2/9/2021. Patient expired 3/11/2021.
"It looks like Covid arm"; body aches; hot to touch; a 2-inch diam raised red bump at injection site; muscle aches; tender; red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION ("It looks like Covid arm"), PAIN (body aches), VACCINATION SITE WARMTH (hot to touch), VACCINATION SITE NODULE (a 2-inch diam raised red bump at injection site) and MYALGIA (muscle aches) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B21A and 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Arrhythmia (Patient's past medical history includes Abnormal heart rhythm.). Concurrent medical conditions included Hypertension.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Mar-2021, the patient experienced VACCINATION SITE REACTION ("It looks like Covid arm"), PAIN (body aches), VACCINATION SITE WARMTH (hot to touch), VACCINATION SITE NODULE (a 2-inch diam raised red bump at injection site), MYALGIA (muscle aches), VACCINATION SITE PAIN (tender) and VACCINATION SITE ERYTHEMA (red). At the time of the report, VACCINATION SITE REACTION ("It looks like Covid arm"), PAIN (body aches), VACCINATION SITE WARMTH (hot to touch), VACCINATION SITE NODULE (a 2-inch diam raised red bump at injection site), MYALGIA (muscle aches), VACCINATION SITE PAIN (tender) and VACCINATION SITE ERYTHEMA (red) had resolved.            No concomitant medication and Treatment information was provided.  Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Outcome of events were updated.
The patient's second dose of Moderna was given to the patient one week prior to when she was to have the vaccine.  The patient was not to have their vaccination till 12/22/21 or later.
bleeding at the injection site and a bruise the size of an apple.; bleeding at the injection site and a bruise the size of an apple.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HAEMORRHAGE (bleeding at the injection site and a bruise the size of an apple.) and VACCINATION SITE BRUISING (bleeding at the injection site and a bruise the size of an apple.) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE HAEMORRHAGE (bleeding at the injection site and a bruise the size of an apple.) and VACCINATION SITE BRUISING (bleeding at the injection site and a bruise the size of an apple.). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE HAEMORRHAGE (bleeding at the injection site and a bruise the size of an apple.) and VACCINATION SITE BRUISING (bleeding at the injection site and a bruise the size of an apple.) had resolved. Unknown          Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medications provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: Outcome of the events was updated to recovered/resolved.
This spontaneous report as received from a medical assistant refers to a 10 week old patient of unknown gender. The concurrent conditions, drug reactions/allergies and medical history of the patient were not reported. On 06-DEC-2016, the patient was vaccinated with a dose of improperly stored ROTATEQ orally with lot number M029252 and expiration date of 14-MAR-2018 (strength and dose were not reported) for prophylaxis, which was stored at 1.1 Celsius degrees (°C) for 27 minutes, 0.7 °C for 19 minutes, 1.1 °C for 36 minutes, 0.7 °C for 29 minutes, 1.3 °C for 17 minutes, 1.1 °C for 20 minutes, 0.9 °C for 26 minutes, 0.7 °C for 31 minutes and 1.2 °C for 24 minutes. There was no previous temperature excursion. Moreover, the temperature excursions were detected by a data logger. No concomitant therapies nor adverse effect were reported. No product quality complaint was involved. This is one of several cases from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1701USA007921: US-009507513-1701USA007910: US-009507513-1701USA004148: US-009507513-1701USA003168: Original Case : 1701USA004152; US-009507513-1701USA007912: US-009507513-1701USA007922: US-009507513-1701USA007881: US-009507513-1701USA007913: US-009507513-1701USA007882: US-009507513-1701USA004150: US-009507513-1701USA007958: US-009507513-1701USA007906: US-009507513-1701USA007895: US-009507513-1701USA007896: US-009507513-1701USA007923: US-009507513-1701USA007883: US-009507513-1701USA007897: US-009507513-1701USA007905: US-009507513-1701USA007884: US-009507513-1701USA007924: US-009507513-1701USA007925: US-009507513-1701USA007847: US-009507513-1701USA007885: US-009507513-1701USA007908: US-009507513-1701USA007909: US-009507513-1701USA007898: US-009507513-1701USA007914: US-009507513-1701USA007915: US-009507513-1701USA007916: US-009507513-1701USA007848: US-009507513-1701USA007849.
Rather intense headache still active after 24hrs. I do not normally get headaches. Sore arm - getting better after 24hrs
Patient slipped through registration w/ DOB.  Pt is only 16 years old and vaccine is not indicated or approved for this age.  Did not realize pt received the vaccine until it was being entered into the computer.  Family contacted immediately and dose 2 of the series WILL NOT be given until authorized by state/manufacture
Patient developed rash head to feet the day after received RABAVERT. Rash is isolated pink macules and papules. Itchy.
exposed to COVID-19, got sick but does not test positive; typical symptoms post vaccination; chills; body aches/aches; Feel sick; non-productive cough; This spontaneous case was reported by a physician and describes the occurrence of MALAISE (Feel sick), COUGH (non-productive cough), EXPOSURE TO SARS-COV-2 (exposed to COVID-19, got sick but does not test positive), VACCINATION COMPLICATION (typical symptoms post vaccination) and CHILLS (chills) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   In December 2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Jul-2021, the patient experienced MALAISE (Feel sick), COUGH (non-productive cough), CHILLS (chills) and MYALGIA (body aches/aches). On an unknown date, the patient experienced EXPOSURE TO SARS-COV-2 (exposed to COVID-19, got sick but does not test positive) and VACCINATION COMPLICATION (typical symptoms post vaccination). At the time of the report, MALAISE (Feel sick), COUGH (non-productive cough), EXPOSURE TO SARS-COV-2 (exposed to COVID-19, got sick but does not test positive), VACCINATION COMPLICATION (typical symptoms post vaccination), CHILLS (chills) and MYALGIA (body aches/aches) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   Reportedly, the patient's respiratory panel looked at 14-16 panels including, flu A, flu B, RSV, Corona virus, etc. and he was negative for all test. The patient had also  taken 3 antigen tests and those were all negative as well.  Treatment information was not provided.     This case was linked to MOD-2021-268351 (Patient Link).
Had UTI. Got myself over the counter meds. I knew what to get because I had same thing with my 1st Moderna vaccine. Same number of days later!  Have not had one since.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 45-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 03Mar2021 at 15:00 as dose 1, single (Lot number: EN6200), in left arm, on 25Mar2021 at 15:45 as dose 2, single (Lot number: EP7534), in left arm and on 18Oct2021 at 10:00 as dose 3 (booster), single (Lot number: FF2589) at the age of 45 years for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "PCOS" (unspecified if ongoing); "Autoimmune disease" (unspecified if ongoing), notes: Autoimmune disease. Concomitant medication(s) included: VALSARTAN; LEVOTHYROXINE. The following information was reported: COVID-19 (medically significant), VACCINATION FAILURE (medically significant) all with onset 07May2022, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (05May2022) Negative; (07May2022) Positive. Therapeutic measures were taken as a result of covid-19, vaccination failure.  Clinical course: It was reported that patient took paxlovid. Started feeling better. Stopped May 1st and by evening started getting fever again at 99 to 100. Next morning got black eye from bruise from just wiping gently on left eye the sleep dust in morning. Then went to ER to check on platelets. All bloodwork was good so went home. Then tested negative on rapid on Thursday 05May2022 and then started having symptoms of red eye, sore throat, postnasal drip, and nerve pain in hands starting on Thursday and Friday 05May and 06May. Tested again on Saturday, 07May2022 and was very dark line positive.
Site: Swelling at Injection Site-Severe, Additional Details: patient came to pharmacy to report inflammation under the armpit after administration of his shot. He got the shot on 6/6/2021 by a nurse practitioner, he is reporting the issue on November 3rd 2021. He claims the shot was given to low on his arm. He says that due to faulty administration he had inflammation under his armpit and subsequently was hospitalized and needed shoulder surgery.
ARTHRITIS; MOUTH ULCERS (SORES); MUSCLE TWITCHING; MUSCLE PAIN; PAIN IN STOMACH; SWOLLEN TONGUE WITHIN 15MINUTES OF ADMINISTRATION; This spontaneous report received from a patient via a company representative concerned a 52 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: non-alcohol user, and non-smoker, and other pre-existing medical conditions included: The patient had no known allergies. The patient had no history of drug abuse or illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 204B221A, and expiry: UNKNOWN) dose was not reported, administered on 26-SEP-2021 for prophylactic vaccination. No concomitant medications were reported.  On 26-SEP-2021, the patient experienced swollen tongue within 15 minutes of administration. On 05-OCT-2021, the patient experienced pain in stomach, arthritis, mouth ulcers (sores), muscle twitching, and muscle pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from pain in stomach, swollen tongue within 15minutes of administration, arthritis, mouth ulcers (sores), muscle twitching, and muscle pain. This report was non-serious.
Fever 102.2; This case was reported by a other health professional via interactive digital media and described the occurrence of fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced fever. On an unknown date, the outcome of the fever was unknown.   It was unknown if the reporter considered the fever to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The patient received Shingrix and had Fever.
Within two weeks of my second dose of the Pfizer vaccine, I began experiencing paresthesia, chronic fatigue, brain fog, difficulty concentrating, chills, dizziness and others. . I messaged my primary care and we began trying to treat the symptoms. Since then I've had MRIs, nerve tests, taken medication for ADHD, altered exercise and diet habits, and have been unable to get rid of my symptoms. It's affected my ability to work and my quality of life greatly.
pt recvd vax;exp vasovagal rxn p/ vax;no true LOC & no sz;felt fatigue;
A report was received from a healthcare professional on 22Nov02 concerning a group of vaccinees less than 4 year old of unk demography who inadvertently received Fluvirin from approx 07Nov02 onwards. From 07Nov02 Fluvirin was administered to vaccinees less than 4 years old. There were no reported adverse events. There was insufficient information to determine the reporter's causality assessment. Update 1 10Dec02: A follow up report was received from a health professional indicated that a 9 month old female was inadvertently administered Fluvirin IM on 18Nov02. Cross reference: PJP200200848, PJP200200805,  PJP200200850, PJP200200851, PJP200200852,PJP200200853,PJP200200854,PJP200200855,PJP200200856,PJP200200857,PJP200200858,PJP200200859,PJP200200860,PJP200200861,PJP200200862,PJP200200863,PJP200200864,PJP200200866,PJP200200867,PJP200200868,PJP200200869,PJP200200870,PJP200200871,PJP200200872,PJP200200873,PJP200200874,PJP200200875,PJP200200876,PJP200200877.
Patient complained about pain in arm after shot.  Diarrhea in the morning, approx. 20 hrs after injection. Patient unable to leave bed and complains of pain in stomach. Currently, at 11 a.m., still in bed.
Pain initially started 24-48 hours after the vaccine injection. Pain is at injection site, and surrounding area. Seems to be worsening since that time. She has tried over-the-counter Tylenol/Ibuprofen and topical Diclofenac gel with little to no relief of her pain. This is made daily living difficult. She also works as a daycare provider. She had some increased headaches 2-3 days after the vaccine, but these have seemed to resolve.
13JUN96 pt recv vax (titer neg) & 17JUN96 pt reported about 20 chicken pox lesions;19JUN96 office visit sever vesicular rash (chicken pox) over entire body;